Matching-adjusted indirect comparisons of efficacy of BAY 81-8973 vs two recombinant factor VIII for the prophylactic treatment of severe hemophilia A

BACKGROUND: No head-to-head trials comparing recombinant factor VIII (rFVIII) products currently exist. This was a matching-adjusted indirect comparison (MAIC) study of efficacy of BAY 81-8973 with antihemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) and turoctocog alfa for the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pocoski, Jennifer, Li, Nanxin, Ayyagari, Rajeev, Church, Nikki, Maas Enriquez, Monika, Xiang, Quer, Kelkar, Sneha, Du, Ella X, Wu, Eric Q, Xie, Jipan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938137/
https://www.ncbi.nlm.nih.gov/pubmed/27445511
http://dx.doi.org/10.2147/JBM.S104074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938137/
https://www.ncbi.nlm.nih.gov/pubmed/27445511
http://dx.doi.org/10.2147/JBM.S104074

Ejemplares similares